Researchers have developed a mindfulness therapy tailored specifically to appeal to teenagers to help them cope with increasing levels of depression and mental health problems.
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Globally, an estimated 5 percent of adults live with depression. (Daniel Reche/Pexels ... "What if we can track the body temperature of people with depression to time heat-based treatments well?" The ...
These agents increase the treatment options for the rare, difficult patient who is recalcitrant to conventional regimens or intolerant of first-line medications. Limited clinical experiences ...
who also directs the Center for Depression, Anxiety, and Stress Research at McLean. “We’re really interested in evaluating whether by using tools of neuroscience, we can get to the correct treatment ...
Dementia treatment is more than just medication ... As neuron loss occurs, other symptoms can occur, including depression, anxiety, agitation, and psychosis. These are known as behavioral ...